Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis

Published:2024-04-08 Issue:6 Volume:309 Page:2323-2338
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Vahabi Dastjerdi Mozhgan,Sheibani Samaneh,Taheri Maryam,Hezarcheshmeh Fouzieh Karami,Jahangirian Jamileh,Jazayeri Maryam,Hosseinirad Hossein,Doohandeh Tahereh^ORCID,Valizadeh Rohollah

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00404-024-07442-0.pdf

Reference44 articles.

1. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N (2021) Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci 28(7):2050–2059. https://doi.org/10.1007/s43032-021-00483-9

2. Bastami F, Vares P, Khojasteh A (2017) Healing effects of platelet-rich plasma on peripheral nerve injuries. J Craniofac Surg 28(1):e49–e57. https://doi.org/10.1097/scs.0000000000003198

3. Berkkanoglu M, Ozgur K (2010) What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril 94(2):662–665. https://doi.org/10.1016/j.fertnstert.2009.03.027

4. Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, Seli E et al (2020) Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany, NY) 12(11):10211–10222. https://doi.org/10.18632/aging.103403

5. Cakiroglu Y, Yuceturk A, Karaosmanoglu O, Kopuk SY, Korun ZEU, Herlihy N, Seli E et al (2022) Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging (Albany, NY) 14(6):2513–2523. https://doi.org/10.18632/aging.203972